Sample policy · Adult social care

Medication management policy (adult social care)

1. Purpose

This policy sets out how the Service manages medicines safely, including administration, storage, transport, disposal, records, refusals, covert administration, PRN medicines, errors and learning.

The Service must verify this policy against NICE social-care medicines guidance, CQC medicines guidance, medicines legislation, controlled-drug requirements and local pharmacy procedures before adoption.

2. Sources to verify before adoption

3. Scope

This policy applies to:

It applies to prescribed medicines, non-prescription medicines, homely remedies where used, topical preparations, nutritional supplements and controlled drugs.

4. MAR chart standards

The Service keeps a current medicine administration record for each person receiving medicines support.

MAR records include:

Staff do not transcribe medicines unless they are trained and authorised under the Service procedure. Any handwritten or amended entry is checked according to current NICE SC1 guidance and local pharmacy process.

5. Administration, storage, transport and disposal

Medicines are administered only by staff who are trained, competent and authorised for that task.

The Service:

The Service verifies storage, transport and disposal detail against NICE SC1, CQC medicines guidance and pharmacy advice before adoption.

6. Controlled-drug register

Where the Service holds controlled drugs requiring register controls, the Service keeps a controlled-drug register.

The register records:

The Registered Manager sets the reconciliation cadence from current controlled-drug legislation, NICE SC1, pharmacy advice and local procedure. This template does not restate controlled-drug legal intervals.

Any discrepancy is escalated immediately to the senior person on duty and Registered Manager.

7. Refusal of medication

A person can refuse medicine if they have capacity for that decision.

When a person refuses medicine, staff:

Refusal patterns are reviewed through care-plan review and medicines audit.

8. Covert administration MCA pathway

Covert administration is used only where the person lacks capacity for the specific medicine decision and the process is lawful, necessary and in the person's best interests.

Before covert administration starts, the Service records:

Covert administration is never used for staff convenience. The Service verifies the process against the Mental Capacity Act 2005, NICE SC1 and CQC medicines guidance before adoption.

9. PRN protocols

Each PRN medicine has a person-specific protocol.

The protocol records:

Staff record the reason for giving PRN medicine and the outcome.

10. Medication review with prescribers

The Service supports regular medication review with prescribers, pharmacists and relevant healthcare professionals.

Review is considered:

The Service does not set clinical review intervals from this template. Staff check NICE SC1, prescriber advice and local medicines pathway.

11. Medication errors and learning

Medication errors and near misses are recorded as incidents.

Staff:

The Registered Manager reviews medication incident themes at least monthly.

12. Staff competency assessment

Staff administer medicines only after training and competency assessment.

Competency covers:

Competency is reassessed after concern, incident, long absence or procedure change.

13. Audit cadence

The Registered Manager audits medicines practice at least monthly.

The audit includes:

Audit findings are recorded as improvement actions with an owner and review date.

Review cadence: annual or on regulatory change, whichever sooner. Owner: Registered Manager.

Related Verivius content

Want help adapting this to your service?

A Verivius consultant can read your adapted policy against the live regulation and your service shape. The work fits inside a Mock Inspection engagement or a shorter consulting brief. A 20-minute conversation is the fastest way to find out whether the fit is right.

Book a 20-minute design-partner conversation

50% off for 12 months. Mock Inspection at the design-partner rate.

Last reviewed 21 May 2026